Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
10.50
-0.02 (-0.19%)
At close: Mar 9, 2026, 4:00 PM EDT
10.76
+0.26 (2.48%)
After-hours: Mar 9, 2026, 4:00 PM EDT

Valneva SE Revenue

Valneva SE had revenue of 29.41M EUR in the quarter ending September 30, 2025, a decrease of -35.82%. This brings the company's revenue in the last twelve months to 179.91M, up 13.48% year-over-year. In the year 2024, Valneva SE had annual revenue of 169.58M with 10.32% growth.

Revenue (ttm)
179.91M EUR
Revenue Growth
+13.48%
P/S Ratio
4.46
Revenue / Employee
257,017 EUR
Employees
700
Market Cap
942.29M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020110.32M-15.88M-12.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Arvinas 262.60M
Maravai LifeSciences Holdings 185.74M
Geron 183.88M
ARS Pharmaceuticals 142.77M
uniQure 16.10M
Arbutus Biopharma 14.61M
Aktis Oncology 5.56M
Revenue Rankings